
    
      This will be a single centre, eight week, randomized, examiner-blind, three treatment,
      parallel group, stratified study. It will be conducted in healthy participants, with at least
      two sensitive teeth that meet all of the study criteria at the Screening and Baseline visits.
      DH will be assessed at Baseline, and after 4 and 8 weeks twice daily treatment.
    
  